StockNews.com Begins Coverage on LifeVantage (NASDAQ:LFVN)

Analysts at StockNews.com initiated coverage on shares of LifeVantage (NASDAQ:LFVN – Get Rating) in a note issued to investors on Wednesday. The brokerage set a “strong-buy” rating on the stock.

LifeVantage Price Performance

LifeVantage stock opened at $3.83 on Wednesday. LifeVantage has a 12 month low of $3.46 and a 12 month high of $6.68. The stock has a market capitalization of $48.14 million, a PE ratio of 95.75 and a beta of 1.10. The business has a 50 day simple moving average of $3.80 and a 200-day simple moving average of $3.89.

LifeVantage (NASDAQ:LFVN – Get Rating) last issued its quarterly earnings results on Wednesday, November 2nd. The company reported $0.06 EPS for the quarter. LifeVantage had a return on equity of 9.48% and a net margin of 0.20%. The firm had revenue of $51.77 million during the quarter. On average, equities research analysts anticipate that LifeVantage will post 0.33 EPS for the current fiscal year.

Institutional Trading of LifeVantage

Large investors have recently made changes to their positions in the company. Private Advisor Group LLC purchased a new stake in shares of LifeVantage during the second quarter worth approximately $49,000. Tower Research Capital LLC TRC boosted its stake in LifeVantage by 117.5% during the third quarter. Tower Research Capital LLC TRC now owns 11,362 shares of the company’s stock worth $42,000 after buying an additional 6,138 shares during the last quarter. O Shaughnessy Asset Management LLC boosted its stake in LifeVantage by 61.8% during the second quarter. O Shaughnessy Asset Management LLC now owns 24,368 shares of the company’s stock worth $106,000 after buying an additional 9,312 shares during the last quarter. American Century Companies Inc. boosted its stake in LifeVantage by 30.3% during the first quarter. American Century Companies Inc. now owns 46,016 shares of the company’s stock worth $219,000 after buying an additional 10,706 shares during the last quarter. Finally, State Street Corp boosted its stake in LifeVantage by 7.6% during the first quarter. State Street Corp now owns 46,191 shares of the company’s stock worth $220,000 after buying an additional 3,281 shares during the last quarter. 29.69% of the stock is currently owned by hedge funds and other institutional investors.

About LifeVantage

(Get Rating)

LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The firm operates through the following geographical segments: Americas Region, and Asia/Pacific and Europe Region. Its products include Protandim, LifeVantage Omega+ and ProBio, TrueScience and Petandim for dogs.